Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CGEM)

CUSIP: 230031106

Q2 2023 13F Holders as of 30 Jun 2023

Security identity
Shares outstanding
61,676,366
Holder snapshot
Share change
+4,483,983
Put/Call ratio
1139%
Reported price per share
$10.76
Number of holders
102
Value change
+$48,696,476
Number of buys
52
Number of sells
56

Security key

230031106

Report period

Q2 2023

Institutions

102

Top holders

10

Ownership snapshot

Top reported holders of CGEM - Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
MPM BioImpact LLC
13D/G signal
Evidence rows
15
Latest as of
31 Mar 2023
13F Lead comparable stake: 12% Showing 1-6 of 15 holder rows.

Rank 3 holder

BVF INC/IL

13F
Ownership
5.2%
Position
$32.7M
13F
Holder Evidence Ownership % Position 12M Net Δ As of
MPM BioImpact LLC
13F
Company
13F
12%
$78,241,782
7,648,268 shares
31 Mar 2023
CHI Advisors LLC
13F
Company
13F
5.4%
$34,264,977
3,349,460 shares
31 Mar 2023
BVF INC/IL
13F
Company
13F
5.2%
$32,702,251
3,196,701 shares
31 Mar 2023
VANGUARD GROUP INC
13F
Company
13F
4.1%
$26,137,527
2,554,988 shares
31 Mar 2023
BlackRock Finance, Inc.
13F
Company
13F
3.7%
$23,074,757
2,255,597 shares
31 Mar 2023
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
13F
2%
$12,647,851
1,236,349 shares
31 Mar 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
102
Shares
36,693,312
Rows available
102
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders
97
Q2 2023 holders
102
Holder diff
5
Investor Q1 2023 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2023 value Q2 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .